MannKind reports plans to price public offering of common-share units

Company sells shares with warrants through Jefferies and Piper Jaffray

By Devika Patel

Knoxville, Tenn., Oct. 17 - MannKind Corp. plans to price a public offering of units, according to a preliminary prospectus supplement filed Wednesday with the Securities and Exchange Commission. The units will also be sold in a private placement to Mann Group LLC.

The units consist of common shares and warrants.

Jefferies and Piper Jaffray are the joint bookrunning managers.

Proceeds will be used for general corporate purposes, including research and development, capital expenditures, working capital and general administrative expenses. The company may also use a portion of the proceeds to acquire or invest in complementary businesses, products and technologies.

Valencia, Calif.-based MannKind is a biopharmaceutical company specializing in the discovery, development and commercialization of therapeutic products for diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.